VIVUS, Inc.
| Article | Date | Source |
|---|
| After going it alone, Vivus finally open to Big Pharma sales partnership | May 09, 2013 | FiercePharma |
| With Qsymia sales sputtering, Vivus shares take a dive | February 26, 2013 | FiercePharma |
| Technical Analysis on VIVUS and Achillion Pharma: Highlights on These Biotech Companies | February 26, 2013 | Biotech News - PR Newswire |
| Resumen: Catalent suscribe acuerdo de suministro comercial con VIVUS para la provisión de las cápsulas de Qsymia TM combinadas de liberación prolongada de una dosis diaria | October 04, 2012 | FDA News - Business Wire |
| Samenvatting: Catalent Pharma Solutions heeft een leveranciersovereenkomst getekend met VIVUS voor de levering van Qsymia capsules, een combinatie van phentermine en topiramaat | October 04, 2012 | FDA News - Business Wire |
| Vivus says Qsymia lawsuit dismissed | October 03, 2012 | Health News - CNBC |
| Riassunto: Catalent sottoscrive accordo di fornitura commerciale con VIVUS per le compresse combinate a rilascio prolungato Qsymia™ da assumere una volta al giorno | October 01, 2012 | FDA News - Business Wire |
| Catalent Enters into Commercial Supply Agreement with VIVUS for Qsymia™ Once-Daily Combination-Extended-Release Capsules | October 01, 2012 | FDA News - Business Wire |
| Catalent schließt kommerzielle Liefervereinbarung mit VIVUS für die einmal täglich einzunehmende Kombinationskapsel Qsymia™ ab | October 01, 2012 | FDA News - Business Wire |
| Catalent conclut un accord commercial avec VIVUS pour la fourniture des pilules de Qsymia™ en traitement combiné à libération prolongée en prise unique quotidienne | October 01, 2012 | FDA News - Business Wire |
| VIVUS To Present New Data On Qsymia™ At 30th Annual Scientific Meeting of The Obesity Society | September 20, 2012 | Biotech News - PR Newswire |
| Analysts eye generic threat as Vivus rolls out Qsymia | September 18, 2012 | FierceBiotech |
| VIVUS Announces Availability Of Once Daily Qsymia™ (Phentermine And Topiramate Extended-Release) Capsules CIV | September 18, 2012 | Pharma News - PR Newswire |
| Vivus Beats Arena Pharma With Obesity Drug Launch | September 17, 2012 | Health News - CNBC |
| Vivus tumbles on concerns about generic Qsymia | August 17, 2012 | Health News - CNBC |
| Vivus shares drop amid speculation about IP threats to diet drug | July 20, 2012 | FierceBiotech |
| Vivus falls on concerns of patent protection for diet pill | July 19, 2012 | Health News - CNBC |
| Sector Snap: Obesity drugmakers Vivus and Arena | July 18, 2012 | Health News - CNBC |
| Can Vivus diet drug beat Arena's Belviq? | July 18, 2012 | FiercePharma |
| FDA approves Vivus drug for weight loss | July 18, 2012 | Health News - BizJournals.com |
| Vivus weight loss drug gets FDA's OK | July 18, 2012 | Health News - BizJournals.com |
| Vivus Weight Loss Pill Wins FDA Approval | July 18, 2012 | Health News - CNBC |
| Ahead of the Bell: Vivus upgraded | July 18, 2012 | Health News - CNBC |
| FDA approves Vivus weight-loss pill Qsymia | July 18, 2012 | Health News - CNBC |
| Vivus Announces FDA Approval of Once Daily Qsymia™ (Phentermine and Topiramate Extended-release) Capsules CIV | July 18, 2012 | Biotech News - PR Newswire |
| FDA approves Vivus weight-loss drug Qsymia | July 18, 2012 | Health News - BizJournals.com |
| UPDATED: FDA hits green light on Vivus weight drug Qnexa | July 17, 2012 | FierceBiotech |
| Vivus Wins FDA Approval for Obesity Drug, After Long, Messy Day | July 17, 2012 | Xconomy Life Sciences |
| BREAKING: FDA hits green light on Vivus weight drug Qnexa | July 17, 2012 | FierceBiotech |
| Oops! Vivus awaits weight-loss drug approval, even as story breaks | July 17, 2012 | Health News - BizJournals.com |
| Investors on high alert as D-Day arrives for Vivus's Qnexa | July 17, 2012 | FierceBiotech |
| Sector Wrap: Vivus and Orexigen trade higher | July 16, 2012 | Health News - CNBC |
| Vivus rises on obesity drug approval for Arena | June 27, 2012 | Health News - CNBC |
| Vivus shares slide as FDA delays decision on Qnexa | April 10, 2012 | FierceBiotech |
| Vivus Diet Drug Approval Decision Postponed to July | April 10, 2012 | Health News - CNBC |
| Finish Line, RIM, Vivus are market movers | March 30, 2012 | Health News - CNBC |
| Vivus shares continue to rise after 4Q report | February 29, 2012 | Health News - CNBC |
| Vivus basks in limelight of rampant M&A speculation | February 29, 2012 | FierceBiotech |
| Vivus shares soar after FDA panel vote on obesity drug | February 23, 2012 | Health News - BizJournals.com |
| Now, Vivus has to gear up for probable Qnexa launch | February 23, 2012 | FiercePharma |
| Vivus Soars on FDA Endorsement of Obesity Pill | February 23, 2012 | Health News - CNBC |
| UPDATE: Vivus soars after experts offer surprising support for weight drug | February 22, 2012 | FierceBiotech |
| The skinny on Vivus obesity drug: safety issues, FDA says | February 17, 2012 | Health News - BizJournals.com |
| FDA raises safety concerns for Vivus diet pill | February 17, 2012 | Health News - CNBC |
| FDA notes concerns about Vivus diet pill safety ahead of panel | February 17, 2012 | FierceBiotech |
| Vivus obesity drug may get broader label | January 09, 2012 | Health News - CNBC |
| Vivus ([[VVUS +15.9%) shares surge after it says the FDA has asked the pharmaceutical company to remove the restriction against use by women of childbearing age on the proposed label for the weight-loss drug Qnexa. | January 09, 2012 | Pharmaceutical - Moreover |
| Vivus buoyed by FDA's willingness to drop Qnexa restriction | January 09, 2012 | FierceBiotech |
| VIVUS Provides Qnexa Regulatory Update | January 09, 2012 | Biotech News - PR Newswire |
| VIVUS to Present at the 2012 JP Morgan Healthcare Conference | January 04, 2012 | Medical Pharma - PR Newswire |
| VIVUS Announces Date of FDA Advisory Committee Review of Qnexa for the Treatment of Obesity | December 23, 2011 | Pharma News - PR Newswire |
| FDA gives new shot to Vivus obesity drug | November 04, 2011 | FierceBiotech |
| VIVUS to Present at the Credit Suisse 2011 Healthcare Conference | November 03, 2011 | Pharma News - PharmiWeb |
| Vivus gets back in the race for weight-loss drug OK, resubmits Qnexa | October 17, 2011 | FierceBiotech |
| VIVUS Resubmits Qnexa NDA to the FDA | October 17, 2011 | Biotech News - PR Newswire |
| VIVUS to Present at the BioCentury NewsMakers Conference | October 14, 2011 | Biotech News - PR Newswire |
| Vivus shares buoyed as FDA allows early resubmission on Qnexa | September 15, 2011 | FierceBiotech |
| Ahead of the Bell: Vivus to resubmit Qnexa to FDA | September 15, 2011 | Health News - CNBC |
| VIVUS Provides Regulatory Update on QNEXA | September 15, 2011 | Pharma News - PR Newswire |
| FDA to decide on Vivus erectile dysfunction by end of April | September 02, 2011 | Health News - BizJournals.com |
| VIVUS Announces FDA Acceptance of Avanafil New Drug Application for Treatment of Erectile Dysfunction | September 01, 2011 | Pharma News - PR Newswire |
| VIVUS Reports Second Quarter and First Six Months 2011 Financial Results | August 01, 2011 | Biotech News - PR Newswire |
| Vivus submits NDA for ED drug | July 01, 2011 | FierceBiotech |
| Vivus files for FDA approval of impotence drug | June 30, 2011 | Health News - CNBC |
| VIVUS Submits New Drug Application for Avanafil for the Treatment of Erectile Dysfunction | June 30, 2011 | Clinical Trials - PR Newswire |
| VIVUS to Participate in Two Investor Conferences in June | June 14, 2011 | Medical Pharma - PR Newswire |
| Orexigen ([[OREX -33%) peer Vivus (VVUS) is moving down in sympathy, with shares -2.2%. Arena Pharmaceutical (ARNA) hasn't started trading yet, but is worth keeping an eye on as well. (OREX's regulatory update) | June 03, 2011 | Pharmaceutical - Moreover |
| Vivus readies NDA as Ph3 trial hits goals for ED drug | May 25, 2011 | FierceBiotech |
| VIVUS Announces Positive Phase 3 Results of Avanafil in Radical Prostatectomy Patients | May 25, 2011 | Biotech News - PR Newswire |
| Vivus eyes path to a limited approval for obesity drug | May 03, 2011 | FierceBiotech |
| Vivus trims 1st-quarter loss on lower spending | May 03, 2011 | Health News - CNBC |
| VIVUS Reports First Quarter 2011 Financial Results | May 02, 2011 | Biotech News - PR Newswire |
| VIVUS to Present at Four Upcoming Investor Conferences in May | April 29, 2011 | Biotech News - PR Newswire |
| Vivus shares climb on obesity drug data | April 04, 2011 | Health News - BizJournals.com |
| Vivus surges on fresh batch of promising obesity drug data | April 04, 2011 | FierceBiotech |
| Ahead of the Bell: Vivus shares Qnexa study data | April 04, 2011 | Health News - CNBC |
| VIVUS to Present at the 10th Annual Needham Healthcare Conference | March 29, 2011 | Biotech News - PR Newswire |
| Topiramate birth defect warning hits Vivus shares | March 04, 2011 | Health News - CNBC |
| Analyst Notes: Vivus delivers Qnexa update | March 01, 2011 | Health News - CNBC |
| Vivus to Try Again By Year’s End | February 28, 2011 | Xconomy Life Sciences |
| VIVUS Reports 2010 Fourth Quarter and Full-Year Financial Results | February 28, 2011 | Biotech News - PR Newswire |
| VIVUS to Present at Three Upcoming Investor Conferences in March | February 25, 2011 | Biotech News - PR Newswire |
| Vivus Inc Launched New Anti-Impotence Drug | February 04, 2011 | Pharma News - PharmiWeb |
| GE, Google and Vivus are big market movers | January 21, 2011 | Health News - CNBC |
| FDA wants birth defect data from Vivus ($VVUS) | January 21, 2011 | FierceBiotech |
| Vivus says FDA asks about Qnexa birth defect link | January 21, 2011 | Health News - CNBC |
| Vivus Shares Tumble On Diet Drug Update | January 21, 2011 | Health News - Fox Business |
| Vivus Faces New Safety Issue | January 21, 2011 | Xconomy Life Sciences |
| VIVUS Provides Regulatory Update on QNEXA NDA | January 21, 2011 | Pharma News - PR Newswire |
| VIVUS to Present at the 2011 JP Morgan Healthcare Conference | January 05, 2011 | Pharma News - PR Newswire |
| Vivus asks for weight-loss drug approval in Europe | December 20, 2010 | Health News - CNBC |
| Vivus Applies To Market Obesity Drug Qnexa In EU | December 20, 2010 | Health News - Fox Business |
| Vivus Files European Market Application For Diet Pill Qnexa | December 20, 2010 | Health News - Fox Business |
| VIVUS Files European Marketing Authorization Application for QNEXA® in the Treatment of Obesity | December 20, 2010 | Biotech News - PR Newswire |
| Vivus Submits Document to FDA | December 14, 2010 | Xconomy Life Sciences |
| Vivus Submits Qnexa Response To FDA; Meeting Set For January | December 14, 2010 | Health News - Fox Business |
| VIVUS Submits Briefing Document to FDA, Announces Follow-up Meeting to Discuss QNEXA® | December 14, 2010 | Biotech News - PR Newswire |
| VIVUS Announces Positive Results From Long-Term Phase 3 Study of Avanafil in Erectile Dysfunction | December 06, 2010 | Pharma News - PR Newswire |
| Orexigen Options Suggest Contrave Diet Pill May Avoid Arena, Vivus Delays | December 03, 2010 | Biotechnology - Moreover |
| Vivus sells Muse to Meda for $23.5 million | November 08, 2010 | Health News - CNBC |
| VIVUS Reports Third Quarter and First Nine Months 2010 Financial Results | November 08, 2010 | Pharma News - PR Newswire |
| VIVUS Announces Closing of MUSE Sale | November 08, 2010 | Biotech News - PR Newswire |
| Hyperion Nails Pivotal Trial, ChemoCentryx Aims High Against Crohn’s, Vivus Shot Down by FDA, & More Bay Area Life Sciences News | November 05, 2010 | Xconomy Life Sciences |
| Merck, Monster, Vivus make big market moves | October 29, 2010 | Health News - CNBC |
| Vivus Turned Down by FDA | October 29, 2010 | Xconomy Life Sciences |
| Vivus shares rise on optimism for weight-loss drug | October 29, 2010 | Health News - CNBC |
| Vivus Receives CRL for Obesity Drug but Stocks Go Up | October 29, 2010 | Inside Industry - Gen |
| Vivus Rallies As Drug Indexes Ease | October 29, 2010 | Health News - Fox Business |
| FDA hands Vivus a complete response letter for Qnexa | October 29, 2010 | FierceBiotech |
| BREAKING NEWS: FDA hands Vivus a complete response letter for Qnexa | October 29, 2010 | FierceBiotech |
| FDA Issues Complete Response Letter to VIVUS Regarding New Drug Application for QNEXA® | October 29, 2010 | Biotech News - PR Newswire |
| Vivus Sells Erectile Treatment for $23.5M | October 04, 2010 | Xconomy Life Sciences |
| VIVUS Announces Sale of MUSE Assets to Meda | October 04, 2010 | Pharma News - PR Newswire |
| Vivus Shows Positive Qnexa Results | September 21, 2010 | Burrill Report |
| ConAgra, Buckle, NYT, Vivus among big movers | September 21, 2010 | Health News - CNBC |
| VIVUS Announces QNEXA Presentations at the European Association for the Study of Diabetes (EASD) Annual Meeting | September 21, 2010 | Medical Pharma - PR Newswire |
| Vivus Reports that Late-Stage Data Shows Benefits of Its Antiobesity Drug | September 21, 2010 | Inside Industry - Gen |
| Vivus Study Shows Obesity Treatment Keeps Weight Off for Two Years | September 21, 2010 | Health News - Fox Business |
| Vivus Shares Soar; Drug Indexes Ease | September 21, 2010 | Health News - Fox Business |
| Ahead of the Bell: Vivus rises on Qnexa study data | September 21, 2010 | Health News - CNBC |
| Vivus Reports Positive Long-Term Data On Diet Drug | September 21, 2010 | Health News - Fox Business |
| Vivus Reports that Phase III Data Shows Benefits of Its Antiobesity Drug | September 21, 2010 | Inside Industry - Gen |
| Vivus offers upbeat assessment of two-year Qnexa data | September 21, 2010 | FierceBiotech |
| Equity Research on VIVUS and Sequenom - The Biotech Battle on Obesity | September 10, 2010 | Biotechnology - Moreover |
| VIVUS to Present at the Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference | August 05, 2010 | Pharma News - PR Newswire |
| Vivus slides after analyst downgrades to 'Sell' | August 03, 2010 | Health News - CNBC |
| Stocks to Watch: Imperial Sugar, Vivus and More ... | August 03, 2010 | Health News - CNBC |
| VIVUS Reports Second Quarter and First Six Months 2010 Financial Results | August 02, 2010 | Biotech News - PR Newswire |
| Cypress Bio Gets Buyout Offer, Trius Prepares for IPO, Arena Gains Following Vivus Setback, & More San Diego Life Sciences News | July 22, 2010 | Xconomy Life Sciences |
| Arena shares continue gaining on Vivus setback | July 19, 2010 | Health News - CNBC |
| Vivus Shares Plunge on FDA Panel Rejection of Diet Drug | July 16, 2010 | Health News - Fox Business |
| Vivus Hammered After FDA Panel's 'No' Vote; Orexigen Down, Arena Up | July 16, 2010 | Pharmaceutical - Moreover |
| Vivus tanks, Arena rallies on FDA diet-drug vote | July 16, 2010 | Pharmaceutical - Moreover |
| FDA Panel Rejects Vivus Fat Pill | July 16, 2010 | Burrill Report |
| Vivus Hammered On Panel's View On Weight-loss Drug | July 16, 2010 | Health News - Fox Business |
| Ahead of the Bell: Vivus shares plunge | July 16, 2010 | Health News - CNBC |
| 3rd UPDATE: FDA Panel Rejects Vivus Weight-Loss Drug Qnexa | July 15, 2010 | Health News - Fox Business |
| Vivus: An Option Pricing Case Study | July 15, 2010 | Biotechnology - Moreover |
| FDA Advisory Panel Rejects Vivus Weight-Loss Drug Qnexa | July 15, 2010 | Pharmaceutical - Moreover |
| VIVUS Comments on FDA Advisory Committee Panel Meeting on QNEXA® (phentermine/topiramate) Controlled Release Capsules for the Treatment of Obesity | July 15, 2010 | Biotech News - PR Newswire |
| FDA Panel Rejects Vivus Diet Drug | July 15, 2010 | Health News - Fox Business |
| Vivus Obesity Drug Shot Down by FDA Panel, in Close Vote | July 15, 2010 | Xconomy Life Sciences |
| Vivus Faces Turning Point in Obesity Drug Battle Tomorrow With Arena, Orexigen | July 14, 2010 | Xconomy Life Sciences |
| Vivus weight loss drug faces FDA panel this week | July 13, 2010 | Health News - CNBC |
| Vivus shares jump ahead of FDA review | July 13, 2010 | Health News - BizJournals.com |
| STOCKS NEWS US-Vivus shares up 8.3 pct after obesity pill works | July 13, 2010 | Biotechnology - Moreover |
| Vivus Shares Jump On FDA Meeting Documents | July 13, 2010 | Health News - Fox Business |
| Vivus Jumps Ahead Of FDA Meeting On Diet Drug | July 13, 2010 | Health News - Fox Business |
| Vivus weight loss drug faces safety questions | July 13, 2010 | Health News - CNBC |
| Vivus shares rally after FDA staffers detail Qnexa concerns | July 13, 2010 | FierceBiotech |
| Vivus shares fall ahead of review for obesity drug | July 12, 2010 | Health News - CNBC |
| Rodman & Renshaw lowers Vivus to 'Market Perform' | July 09, 2010 | Health News - CNBC |
| Vivus ED drug passes its second late-stage test | June 07, 2010 | FierceBiotech |
| Vivus says erectile dysfunction drug meets goals | June 07, 2010 | Health News - CNBC |
| VIVUS Announces Positive Results From Phase 3 Study of Avanafil in Diabetics With Erectile Dysfunction | June 07, 2010 | Biotech News - PR Newswire |
| VIVUS To Present at Four Upcoming Investor Conferences | May 10, 2010 | Biotech News - PR Newswire |
| VIVUS Grants Stock Option to New Senior Vice President and Chief Commercial Officer | May 04, 2010 | Biotech News - PR Newswire |
| Vivus 1Q loss widens on dip in revenue | May 03, 2010 | Health News - CNBC |
| VIVUS Reports First Quarter 2010 Financial Results | May 03, 2010 | Pharma News - PR Newswire |
| Vivus Q1 loss balloons to $18.8M | May 03, 2010 | Health News - BizJournals.com |
| VIVUS Appoints Michael Miller to Senior Vice President and Chief Commercial Officer | May 03, 2010 | Biotech News - PR Newswire |
| VIVUS To Present at Deutsche Bank 35th Annual Healthcare Conference | April 29, 2010 | Medical Pharma - PR Newswire |
| Vivus shares rise on analyst note | April 27, 2010 | Health News - CNBC |
| VIVUS to Present at the 2010 Future Leaders in the Biotech Industry Conference | April 01, 2010 | Biotech News - PR Newswire |
| Vivus ends development agreement with FemPharm | March 31, 2010 | Health News - CNBC |
| Vivus hands back rights to testosterone therapy | March 31, 2010 | FierceBiotech |
| Vivus discontinues testosterone development | March 31, 2010 | Health News - BizJournals.com |
| Vivus drops women’s testosterone deal | March 31, 2010 | Health News - BizJournals.com |
| VIVUS Announces Termination of Agreement for the Development of Testosterone MDTS(R) | March 31, 2010 | Pharma News - PR Newswire |
| Vivus says panel will review obesity drug in July | March 26, 2010 | Health News - CNBC |
| FDA panel to review Vivus drug in July | March 26, 2010 | FierceBiotech |
| VIVUS to Present at Barclays Capital 2010 Global Healthcare Conference | March 19, 2010 | Biotech News - PR Newswire |
| Vivus Q4 loss nearly doubles to $13.2M | March 08, 2010 | Health News - BizJournals.com |
| VIVUS Reports 2009 Fourth Quarter and Full-Year Financial Results | March 08, 2010 | Biotech News - PR Newswire |
| VIVUS to Present at Two Upcoming Investor Conferences | March 03, 2010 | Biotech News - PR Newswire |
| Vivus's Qnexa Will Become Decision Resources' Clinical Gold Standard in 2013 for the Treatment of Obesity | March 02, 2010 | Pharma News - PR Newswire |
| FDA Accepts Vivus Application For Obesity Drug | March 01, 2010 | Health News - Fox Business |
| VIVUS Announces FDA Acceptance of Qnexa(R) New Drug Application for Treatment of Obesity | March 01, 2010 | Pharma News - PR Newswire |
| VIVUS to Present at the BIO CEO and Investor Conference | February 04, 2010 | Pharma News - PR Newswire |
| The Skinny On Vivus | January 20, 2010 | Health News - CNBC |
| Vivus posts more positive ED data | January 11, 2010 | FierceBiotech |
| VIVUS Announces Additional Results of Phase 3 avanafil Study in Erectile Dysfunction Showing Efficacy in 15 Minutes | January 11, 2010 | Clinical Trials - PR Newswire |
| Vivus Obesity Drug Also Helps Sleeping Disorder: Study | January 07, 2010 | Health News - Fox Business |
| UPDATE: Vivus Obesity Drug Shows Effectiveness In Sleep Apnea | January 07, 2010 | Health News - Fox Business |
| VIVUS Announces Positive Results From Phase 2 Study of Qnexa in Obstructive Sleep Apnea | January 07, 2010 | Clinical Trials - PR Newswire |
| VIVUS to Present at the 2010 JP Morgan Healthcare Conference | January 05, 2010 | Pharma News - PR Newswire |
| Vivus submits obesity drug to FDA | December 29, 2009 | Health News - BizJournals.com |
| VIVUS Submits Qnexa(R) New Drug Application to the FDA for the Treatment of Obesity | December 29, 2009 | Biotech News - PR Newswire |
